In the unfolding drama of biomedical revolution, a familiar protagonist is taking on new roles. Tumor Necrosis Factor Alpha (TNF-α), a storied cytokine with a history of pivotal roles in immunomodulatory therapy, is shifting the paradigm of its functionality in 2024. Historically targeted for autoimmune disorders, TNF-α is now demonstrating a surprising versatility, expanding its […]